High-Throughput Screening Market trends, segmentation, growth, analysis and forecast 2023-2030
The global high-throughput screening market is anticipated to grow at a considerable CAGR of 7.7% during the forecast period.
Stay updated with breaking news from Orbit Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global high-throughput screening market is anticipated to grow at a considerable CAGR of 7.7% during the forecast period.
Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a focus on the treatment and diagnosis of cancer.
A multi target Research Agreement with Endevica Bio Inc has been announced by Oxford (UK) company Orbit Discovery. Click to read more...
The central focus of the agreement is to establish peptide hits from selected library populations - News - PharmaTimes
Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a multi target Research Agreement with Endevica Bio Inc., (Endevica), a company